TELA Bio (TELA) Share-based Compensation (2018 - 2026)

TELA Bio has reported Share-based Compensation for 9 years, with the latest figure at $3.5 million in Q2 2026.

• On a quarterly basis, Share-based Compensation rose 23.68% year-over-year to $3.5 million in Q2 2026; TTM through Jun 2026 was $3.5 million, a 23.68% increase from a year earlier, with the FY2025 full-year figure at $3.8 million, down 12.98% from the prior year.
• Share-based Compensation was $3.5 million for Q2 2026 at TELA Bio, down from $3.5 million in the prior quarter.
• The five-year high for Share-based Compensation was $3.5 million in Q1 2026, with the low at $812000.0 in Q4 2025.
• Average Share-based Compensation over 5 years is $2.1 million, with a median of $2.2 million recorded in 2023.
• The sharpest annual moves came in 2025 and 2026: Share-based Compensation dropped 25.44% in 2025, then jumped 39.77% in 2026.
• Over 5 years, Share-based Compensation stood at $1.0 million in 2022, then climbed by 19.44% to $1.2 million in 2023, then fell by 12.25% to $1.1 million in 2024, then retreated by 25.44% to $812000.0 in 2025, then soared by 329.23% to $3.5 million in 2026.
• The last three Share-based Compensation figures came in at $3.5 million (Q2 2026), $3.5 million (Q1 2026), and $812000.0 (Q4 2025), per Business Quant data.